Live intraday price
Compare with our price levels
Close 2026-09-30: $11.56 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)
Not in the buy zone yet — needs to drop 12.5% · 1 whale recently bought
🎯 Trade plan by price level
Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks
Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated
Risk : reward 1 : 4.1Moves ~$0.87 a day
⚖️ Positives and risks
- ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
- ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 42.40 (upside +267%, 5 ราย)
- ●นักวิเคราะห์ส่วนใหญ่แนะนำ Strong Buy
- None
🕯️ Price chart
Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold
🐋 Whales holding this stock
From each whale's latest quarterly filing
👔 Insider buying & selling
Latest trades from SEC Form 4 filings
BAIN CAPITAL INVESTORS LLC / Bain Capital XIV General Partner, LLC / Bain Capital Fund XIV, L.P. / BCPE Perseus Investor GP, LLC / BCPE Perseus Investor, LP · 10%+ owner
2026-04-20 · 8,398,438 shares @ $16.00
Kaplan Andrew T. · Director · 10%+ owner
2026-04-20 · 8,398,438 shares @ $16.00
Koppel Adam · Director · 10%+ owner
2026-04-20 · 1,562,500 shares @ $16.00
Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences IV General Partner, LLC / Bain Capital Life Sciences Fund IV, L.P. / BCLS Fund IV Investments GP, LLC / BCLS Fund IV Investments, · 10%+ owner
2026-04-20 · 1,562,500 shares @ $16.00
RTW INVESTMENTS, LP / WONG RODERICK · 10%+ owner
2026-04-20 · 500,000 shares @ $16.00
📊 Past earnings and price reaction
Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days
Actual EPS -$1.09 · est. -$0.73 · After close
Day 1
Next 20 days
Actual EPS -$3.65 · est. -$0.55 · After close
Day 1
Next 20 days
Listen to the earnings call or read the full report on KLRA's investor relations page ↗ · Earnings data from Yahoo Finance
💬 User reviews
Rate and review this stock (sign-in required) — reviews don't affect the system's scores
Loading…
Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person
📰 Latest news
Jim Cramer Calls Kailera Therapeutics (KLRA) “The Most Speculative Stock On Earth”
Insider Monkey · 2026-09-15
Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore
24/7 Wall St. · 2026-08-18
Kailera Therapeutics (KLRA) Reports Wider Losses And Names New CTO, Is The Low P B Justified?
Simply Wall St. · 2026-08-17
2 GLP-1 Stocks That Could Double Your Money by 2031
Motley Fool · 2026-08-16
2 Beaten-Down GLP-1 Stocks to Buy on the Dip
Motley Fool · 2026-07-15
🔬 Deep dive
For those who want the detailed numbers